Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 15;231(4):841-848.
doi: 10.1093/infdis/jiaf029.

Rationale and Ethical Assessment of an Oropharyngeal Gonorrhea Controlled Human Infection Model

Affiliations

Rationale and Ethical Assessment of an Oropharyngeal Gonorrhea Controlled Human Infection Model

Eloise Williams et al. J Infect Dis. .

Abstract

Infection with Neisseria gonorrhoeae, the causative agent of gonorrhea, causes significant morbidity worldwide and can have long-term impacts on reproductive health. The greatest global burden of gonorrhea occurs in low- and middle-income settings. Global public health significance is increasing due to rising antimicrobial resistance, which threatens future gonorrhea management. The oropharynx is an important asymptomatic reservoir for gonorrhea transmission and a high-risk site for development of antimicrobial resistance and treatment failure. Controlled human infection model (CHIM) studies using N gonorrhoeae may provide a means to accelerate the development of urgently needed therapeutics, vaccines, and other biomedical prevention strategies. A gonorrhea urethritis CHIM has been used since the 1980s with no reported serious adverse events. Here, we describe the rationale for an oropharyngeal gonorrhea CHIM, including analysis of potential ethical issues that should inform the development of this novel study design.

Keywords: antimicrobial resistance; controlled human infection model; ethics; gonorrhea; sexually transmitted infection.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

References

    1. Unemo M, Seifert HS, Hook EW 3rd, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers 2019; 5:79. - PubMed
    1. Sawatzky P, Martin I, Thorington R, Alexander D. Disseminated gonococcal infections in Manitoba, Canada: 2013 to 2020. Sex Transm Dis 2022; 49:831–7. - PubMed
    1. Vallely LM, Egli-Gany D, Wand H, et al. . Adverse pregnancy and neonatal outcomes associated with Neisseria gonorrhoeae: systematic review and meta-analysis. Sex Transm Infect 2021; 97:104–11. - PMC - PubMed
    1. Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia 2008; 40:72–5. - PubMed
    1. Ward H, Rönn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:305–10. - PMC - PubMed